157 related articles for article (PubMed ID: 32842685)
1. Identification of the Effects of Aspirin and Sulindac Sulfide on the Inhibition of HMGA2-Mediated Oncogenic Capacities in Colorectal Cancer.
Ekanem TI; Tsai WL; Lin YH; Tan WQ; Chang HY; Huang TC; Chen HY; Lee KH
Molecules; 2020 Aug; 25(17):. PubMed ID: 32842685
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of miR-194 Reverses HMGA2-driven Signatures in Colorectal Cancer.
Chang HY; Ye SP; Pan SL; Kuo TT; Liu BC; Chen YL; Huang TC
Theranostics; 2017; 7(16):3889-3900. PubMed ID: 29109785
[TBL] [Abstract][Full Text] [Related]
3. Aspirin and Sulindac act via different mechanisms to inhibit store-operated calcium channel: Implications for colorectal cancer metastasis.
Wang YS; Huang NK; Lin YC; Chang WC; Huang WC
Biomed Pharmacother; 2022 Jan; 145():112476. PubMed ID: 34864310
[TBL] [Abstract][Full Text] [Related]
4. miR-330 suppresses EMT and induces apoptosis by downregulating HMGA2 in human colorectal cancer.
Mansoori B; Mohammadi A; Naghizadeh S; Gjerstorff M; Shanehbandi D; Shirjang S; Najafi S; Holmskov U; Khaze V; Duijf PHG; Baradaran B
J Cell Physiol; 2020 Feb; 235(2):920-931. PubMed ID: 31241772
[TBL] [Abstract][Full Text] [Related]
5. Gene Expression Signature-Based Approach Identifies Antifungal Drug Ciclopirox As a Novel Inhibitor of HMGA2 in Colorectal Cancer.
Huang YM; Cheng CH; Pan SL; Yang PM; Lin DY; Lee KH
Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31684108
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional activation of FN1 and IL11 by HMGA2 promotes the malignant behavior of colorectal cancer.
Wu J; Wang Y; Xu X; Cao H; Sahengbieke S; Sheng H; Huang Q; Lai M
Carcinogenesis; 2016 May; 37(5):511-21. PubMed ID: 26964871
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of 5-fluorouracil and oxaliplatin on human colorectal cancer cell survival are synergistically enhanced by sulindac sulfide.
Flis S; Spłwiński J
Anticancer Res; 2009 Jan; 29(1):435-41. PubMed ID: 19331183
[TBL] [Abstract][Full Text] [Related]
8. MiR-4500 is epigenetically downregulated in colorectal cancer and functions as a novel tumor suppressor by regulating HMGA2.
Yu FY; Tu Y; Deng Y; Guo C; Ning J; Zhu Y; Lv X; Ye H
Cancer Biol Ther; 2016 Nov; 17(11):1149-1157. PubMed ID: 27686621
[TBL] [Abstract][Full Text] [Related]
9. Gene modulation by the cyclooxygenase inhibitor, sulindac sulfide, in human colorectal carcinoma cells: possible link to apoptosis.
Bottone FG; Martinez JM; Collins JB; Afshari CA; Eling TE
J Biol Chem; 2003 Jul; 278(28):25790-801. PubMed ID: 12734198
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA PCAT6 targets miR-204 to modulate the chemoresistance of colorectal cancer cells to 5-fluorouracil-based treatment through HMGA2 signaling.
Wu H; Zou Q; He H; Liang Y; Lei M; Zhou Q; Fan D; Shen L
Cancer Med; 2019 May; 8(5):2484-2495. PubMed ID: 30938104
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
Fan C; Lin Y; Mao Y; Huang Z; Liu AY; Ma H; Yu D; Maitikabili A; Xiao H; Zhang C; Liu F; Luo Q; Ouyang G
Oncotarget; 2016 Apr; 7(16):21825-39. PubMed ID: 26968810
[TBL] [Abstract][Full Text] [Related]
12. P53-induced miR-1249 inhibits tumor growth, metastasis, and angiogenesis by targeting VEGFA and HMGA2.
Chen X; Zeng K; Xu M; Liu X; Hu X; Xu T; He B; Pan Y; Sun H; Wang S
Cell Death Dis; 2019 Feb; 10(2):131. PubMed ID: 30755600
[TBL] [Abstract][Full Text] [Related]
13. HMGA2 facilitates colorectal cancer progression via STAT3-mediated tumor-associated macrophage recruitment.
Wang X; Wang J; Zhao J; Wang H; Chen J; Wu J
Theranostics; 2022; 12(2):963-975. PubMed ID: 34976223
[No Abstract] [Full Text] [Related]
14. Growth-suppressive effect of non-steroidal anti-inflammatory drugs on 11 colon-cancer cell lines and fluorescence differential display of genes whose expression is influenced by sulindac.
Akashi H; Han HJ; Iizaka M; Nakamura Y
Int J Cancer; 2000 Dec; 88(6):873-80. PubMed ID: 11093808
[TBL] [Abstract][Full Text] [Related]
15. Dicoumarol suppresses HMGA2-mediated oncogenic capacities and inhibits cell proliferation by inducing apoptosis in colon cancer.
Chen CH; Hsieh YC; Yang PM; Liu YR; Cho EC
Biochem Biophys Res Commun; 2020 Apr; 524(4):1003-1009. PubMed ID: 32063361
[TBL] [Abstract][Full Text] [Related]
16. Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1.
Moon Y; Bottone FG; McEntee MF; Eling TE
Mol Cancer Ther; 2005 Oct; 4(10):1551-8. PubMed ID: 16227405
[TBL] [Abstract][Full Text] [Related]
17. HMGA2 promotes intestinal tumorigenesis by facilitating MDM2-mediated ubiquitination and degradation of p53.
Wang Y; Hu L; Wang J; Li X; Sahengbieke S; Wu J; Lai M
J Pathol; 2018 Dec; 246(4):508-518. PubMed ID: 30175854
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cell transformation by sulindac sulfide is confined to specific oncogenic pathways.
Gala M; Sun R; Yang VW
Cancer Lett; 2002 Jan; 175(1):89-94. PubMed ID: 11734340
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer: Implications for chemotherapy.
Liu TP; Huang CC; Yeh KT; Ke TW; Wei PL; Yang JR; Cheng YW
Surg Oncol; 2016 Dec; 25(4):429-434. PubMed ID: 27262492
[TBL] [Abstract][Full Text] [Related]
20. Nonsteroidal anti-inflammatory drugs induce colorectal cancer cell apoptosis by suppressing 14-3-3epsilon.
Liou JY; Ghelani D; Yeh S; Wu KK
Cancer Res; 2007 Apr; 67(7):3185-91. PubMed ID: 17409426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
